Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAPES: Tranilast vs Steroids for Esophageal Stricture
NCT06643689Phase 2Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jan 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of tranilast in Esophageal stricture (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Incidence of esophageal stricture within 16 weeks after cESD. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
tranilast
03
Conditions
Esophageal stricture
Beyond the preview
Go deeper on NCT06643689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06643689.